Premium
Partial Left Ventriculectomy (Batista Procedure) in the Treatment of Dilated Cardiomyopathy: Makati Medical Center Philippine Experience
Author(s) -
Garcia Jorge M.,
Barril Joseph,
Manapat Adrian,
Lopez Gary,
Luna Benjamin
Publication year - 1985
Publication title -
echocardiography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.404
H-Index - 62
eISSN - 1540-8175
pISSN - 0742-2822
DOI - 10.1111/j.1540-8175.1985.tb01278.x
Subject(s) - medicine , ejection fraction , dilated cardiomyopathy , ventricle , cardiology , refractory (planetary science) , heart failure , cardiomyopathy , transplantation , population , heart transplantation , surgery , physics , environmental health , astrobiology
A bstract In the Philippines patients with end‐stage heart disease refractory to conventional medical and surgical treatment do not have alternative choices. More than 99% of the population cannot afford cardiac transplantation. Partial left ventriculectomy (PLV) is a surgical procedure that improves cardiac function and refractory congestive heart failure (CHF). Between October 1997 and February 1998 eight patients had PLV at the Makati Medical Center, Philippines. All patients had end‐stage dilated cardiomyopathy. Six patients had an id‐iopathic etiology, one was ischemic and one valvular. Seven of eight operations were done with the heart beating and all had transesophageal echo monitoring. An average of a 2‐cm reduction in the left ventricle diameter was achieved and ejection fraction improved in all cases. There were no operative deaths. There were three late deaths. Two patients died of refractory CHF and ventricular arrhythmias and one patient died of massive cerebral hemorrhage with coumadin therapy. The five survivors are all doing well with no CHF. Follow‐up two‐dimensional echo shows stable left ventricular (LV) size and improved ejection fraction. Our initial experience shows that PLV, at least in the short‐term, has beneficial effects in the treatment of end‐stage dilated cardiomyopathy and might become an alternative to cardiac transplantation.